Vaccine Development
New non-immunizing, paraspecific vaccines from attenuated pox viruses developed
Published in Vaccine Weekly, April 2nd, 2003
According to recent research from Germany, "The various research periods leading to the development of paraspecific vaccines are described. Paraspecific vaccines are new, pyrogen-free, non-toxic preparations that contain non-immunizing antigens and can be used to generate endogenic protective, non-antigen specific mechanisms in the sense of paramunization in humans and animals."
"They consist of highly attenuated and inactivated (0.05% Betapropiolactone) virus strains of various poxvirus genera," said A. Mayr at Ludwig-Maximilians-University of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2003-04-02)
More Articles from Vaccine Weekly
- Pneumococcal Vaccine
23-Valent pneumococcal revaccination offers short-term protection for elderly - Vaccine Development
Promoter trap system increases expression of protective antigen - Cervical Cancer Vaccine
Dendritic cell vaccine shows promise against cervical cancer - Vaccine Development
Stabilization of dry powder vaccine formulations enhanced by rapid freezing - Vaccine Safety
Enterovirus induces antibody response with islet cell autoantigens in humans - Allergy Medicine Vaccine
Ovalbumin allergenic peptide effective for allergic airway inflammation - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
